A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
Parag Jitendra Parikh, Percy Lee, Daniel A. Low, Joshua Kim, Kathryn E. Mittauer, Michael F. Bassetti, Carri K. Glide-Hurst, Ann C. Raldow, Yingli Yang, Lorraine Portelance, Kyle R. Padgett, Bassem Zaki, Rongxiao Zhang, Hyun Kim, Lauren E. Henke, Alex T. Price, Joseph D. Mancias, Christopher L. Williams, John Ng, Ryan PennellM. Raphael Pfeffer, Daphne Levin, Adam C. Mueller, Karen E. Mooney, Patrick Kelly, Amish P. Shah, Luca Boldrini, Lorenzo Placidi, Martin Fuss, Michael D. Chuong
Dive into the research topics of 'A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer'. Together they form a unique fingerprint.